{"id":510920,"title":"Guidance document: Fecal microbiota therapy used in the treatment of Clostridioides difficile infection not responsive to conventional therapies - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T12:53:34.344000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulation-fecal-microbiota-therapy-treatment-difficile-infections.html","snippet":"Guidance document: Fecal microbiota therapy used in the treatment of Clostridioides difficile infection not responsive to conventional therapies (PDF Version - 316 K) Published by authority of the Minister of Health Date adopted: 2015-03-27 Effective date: 2015-03-27 Revised…","rawSnapshotUrl":"/api/snapshots/raw/510920","browseUrl":"https://replay.healtharchive.ca/job-6/20260216125334/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulation-fecal-microbiota-therapy-treatment-difficile-infections.html#ha_snapshot=510920","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}